Save
Share
SHOULD DIRECT-ACTING ANTIVIRAL BE CONSIDERED FOR ALL PATIENTS WITH HCV-RELATED HEPATOCELLULAR CARCINOMA?
Journal:
Clinical And Molecular Hepatology
Published:
March 05, 2025
Authors
Yan Ong,
Apichat Kaewdech
,
Yu Wong
Relevant Conditions
Hepatitis C
,
Hepatitis
,
Liver Cancer
View Article From Source
Similar Publications
We couldn’t find any related articles. Please check for more on the main search page.